Literature DB >> 30541390

Cytokine Changes in Maternal Peripheral Blood Correlate With Time-to-Delivery in Pregnancies Complicated by Premature Prelabor Rupture of the Membranes.

Stefania Ronzoni1, Valerie Steckle2,3, Rohan D'Souza2,4, Kellie E Murphy2,4, Stephen Lye2,3,4, Oksana Shynlova2,3,4.   

Abstract

Premature prelabor rupture of the membranes (PPROM) causes one-third of preterm births worldwide and is most likely caused by subclinical intrauterine infection and/or inflammation. We proposed that women with systemic inflammation at the time of PPROM would have shorter latency. Peripheral blood samples were collected from 20 singleton pregnant women with PPROM between 23 ± 1 and 33 ± 6 weeks. The first sample was drawn within 48 hours of admission, followed by weekly blood draws until delivery. Pregnancies complicated with acute chorioamnionitis, preeclampsia, intrauterine growth restriction, obesity, substance abuse, and chronic maternal disease were excluded. Twenty uncomplicated, gestational age-matched pregnancies served as controls. Plasma concentration of 39 cytokines was measured longitudinally using Luminex assays to investigate their value as predictive biomarkers of latency. Women with PPROM exhibited significantly lower plasma concentration of interferon-γ-inducible protein 10-Chemokine (c-x-c motif; IP10/CXCL10), Chemokine (c-x-c motif) Ligand 9 (MIG/CXCL9), Platelet-derived growth factor BB (PDGFbb), and cutaneous T cell-attracting chemokine, also known as CCL27/CCL27 than controls at admission but significantly elevated interleukin (IL)1RA, tumor necrosis factor α, monocyte chemotactic protein-1/CCL2 at delivery compared to admission. Women with PPROM who delivered within 7 days had significantly lower plasma concentration of anti-inflammatory cytokine IL1RA than those with latency periods >7 days. The IL1RA and endotoxin activity in conjunction with clinical parameters results in excellent prediction of latency to delivery (area under the receiver-operating characteristic curve = 0.91). We concluded that higher levels of anti-inflammatory cytokines in women with PPROM were associated with increased latency until delivery, likely due to counterbalancing of proinflammatory load. When used in conjunction with other predictive characteristics of time until delivery, cytokines may further assist clinical decision-making and optimize pregnancy outcomes in women with PPROM.

Entities:  

Keywords:  biomarkers; cytokines; intrauterine infection/inflammation; latency to delivery; premature birth; premature rupture of fetal membranes

Mesh:

Substances:

Year:  2018        PMID: 30541390     DOI: 10.1177/1933719118815590

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  5 in total

Review 1.  A Systematic Review of the Safety of Blocking the IL-1 System in Human Pregnancy.

Authors:  Marie-Eve Brien; Virginie Gaudreault; Katia Hughes; Dexter J L Hayes; Alexander E P Heazell; Sylvie Girard
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.964

2.  Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth.

Authors:  Young-Ah You; Eun Jin Kwon; Han-Sung Hwang; Suk-Joo Choi; Sae Kyung Choi; Young Ju Kim
Journal:  BMC Genomics       Date:  2021-07-10       Impact factor: 3.969

Review 3.  Phthalate Exposure and Long-Term Epigenomic Consequences: A Review.

Authors:  Sudipta Dutta; Diana K Haggerty; Daniel A Rappolee; Douglas M Ruden
Journal:  Front Genet       Date:  2020-05-06       Impact factor: 4.772

4.  Association of Dietary Inflammatory Index with Serum IL-6, IL-10, and CRP Concentration during Pregnancy.

Authors:  Joanna Pieczyńska; Sylwia Płaczkowska; Lilla Pawlik-Sobecka; Izabela Kokot; Rafał Sozański; Halina Grajeta
Journal:  Nutrients       Date:  2020-09-11       Impact factor: 5.717

5.  Longitudinal evaluation of azithromycin and cytokine concentrations in amniotic fluid following one-time oral dosing in pregnancy.

Authors:  Rupsa C Boelig; Edwin Lam; Ankit Rochani; Gagan Kaushal; Amanda Roman; Walter K Kraft
Journal:  Clin Transl Sci       Date:  2021-07-26       Impact factor: 4.689

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.